Start Page / Reports / Imatinib (Glivec®) in chronic myeloid leukemia (CML)

Imatinib (Glivec®) in chronic myeloid leukemia (CML)

Report type: Alert
Published: 2003-05-27
Language information: This report is published in Swedish, and is not available in English.
Contact person SBU: Jan Liliemark  E-mail: liliemark@sbu.se